PL353209A1 - Kompozycja farmaceutyczna i sposób jej wytwarzania - Google Patents

Kompozycja farmaceutyczna i sposób jej wytwarzania

Info

Publication number
PL353209A1
PL353209A1 PL00353209A PL35320900A PL353209A1 PL 353209 A1 PL353209 A1 PL 353209A1 PL 00353209 A PL00353209 A PL 00353209A PL 35320900 A PL35320900 A PL 35320900A PL 353209 A1 PL353209 A1 PL 353209A1
Authority
PL
Poland
Prior art keywords
paracetamol
drotaverine
containing composition
active ingredient
additional active
Prior art date
Application number
PL00353209A
Other languages
English (en)
Other versions
PL197749B1 (pl
Inventor
Morvai Magdolna Vitanyine
Peterne Kovacs
Mathe Irma Kalmanne
Boglarka Jakab
Erzsebet Vegeli
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Publication of PL353209A1 publication Critical patent/PL353209A1/pl
Publication of PL197749B1 publication Critical patent/PL197749B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL353209A 1999-07-28 2000-07-28 Trwała kompozycja farmaceutyczna w postaci stałej i sposób jej wytwarzania PL197749B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902559A HU225779B1 (en) 1999-07-28 1999-07-28 Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
PCT/HU2000/000086 WO2001007024A2 (en) 1999-07-28 2000-07-28 Paracetamol and drotaverine containing composition

Publications (2)

Publication Number Publication Date
PL353209A1 true PL353209A1 (pl) 2003-11-03
PL197749B1 PL197749B1 (pl) 2008-04-30

Family

ID=90014235

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353209A PL197749B1 (pl) 1999-07-28 2000-07-28 Trwała kompozycja farmaceutyczna w postaci stałej i sposób jej wytwarzania

Country Status (19)

Country Link
EP (1) EP1200088B1 (pl)
AT (1) ATE241983T1 (pl)
AU (1) AU6308800A (pl)
BG (1) BG65553B1 (pl)
DE (1) DE60003188T2 (pl)
DK (1) DK1200088T3 (pl)
EA (1) EA003779B1 (pl)
EE (1) EE04952B1 (pl)
ES (1) ES2197107T3 (pl)
GE (1) GEP20053581B (pl)
HR (1) HRP20020071B1 (pl)
HU (1) HU225779B1 (pl)
ME (2) MEP18508A (pl)
PL (1) PL197749B1 (pl)
PT (1) PT1200088E (pl)
RS (1) RS50074B (pl)
SI (1) SI1200088T1 (pl)
UA (1) UA72535C2 (pl)
WO (1) WO2001007024A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2232018C2 (ru) * 2002-10-09 2004-07-10 Открытое акционерное общество "Ирбитский химико-фармацевтический завод" Спазмолитическое лекарственное средство
RU2252024C2 (ru) * 2003-04-22 2005-05-20 Гаврилов Андрей Станиславович Способ получения спазмолитического лекарственного средства
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
WO2016075617A1 (en) * 2014-11-11 2016-05-19 Dr. Reddys Laboratories Limited Fixed dose pharmaceutical formulations of analgesic and anti-spasmodic drugs
EP3520781A1 (en) 2018-02-05 2019-08-07 Adamed sp. z o.o. A pharmaceutical composition comprising metamizole, drotaverine, and caffeine
JOP20220209A1 (ar) * 2020-03-09 2023-01-30 Sushma Paul Berlia تركيبات الإطلاق المحكوم مشتملة على الدروتافيرين أو ملحه
CN115397411B (zh) * 2020-04-23 2025-08-22 浙江养生堂天然药物研究所有限公司 药物组合及其用途
BG113694A (bg) 2023-04-26 2024-10-31 "Адифарм" Еад Фармацевтичен състав под формата на таблетка, съдържаща метамизол, кофеин и дротаверин и метод за нейното получаване

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation

Also Published As

Publication number Publication date
SI1200088T1 (en) 2003-12-31
EA003779B1 (ru) 2003-08-28
HUP9902559A2 (hu) 2002-04-29
DK1200088T3 (da) 2003-09-22
WO2001007024A2 (en) 2001-02-01
ATE241983T1 (de) 2003-06-15
BG65553B1 (bg) 2008-12-30
EA200200211A1 (ru) 2002-08-29
YU6102A (sh) 2005-03-15
UA72535C2 (en) 2005-03-15
PL197749B1 (pl) 2008-04-30
BG106368A (en) 2002-08-30
HUP9902559D0 (en) 1999-10-28
EE200200042A (et) 2003-04-15
GEP20053581B (en) 2005-07-25
AU6308800A (en) 2001-02-13
EP1200088A2 (en) 2002-05-02
EP1200088B1 (en) 2003-06-04
WO2001007024A3 (en) 2001-03-29
PT1200088E (pt) 2003-10-31
EE04952B1 (et) 2008-02-15
HRP20020071B1 (hr) 2011-01-31
DE60003188D1 (de) 2003-07-10
ME00088B (me) 2010-10-10
MEP18508A (en) 2010-06-10
RS50074B (sr) 2009-01-22
HU225779B1 (en) 2007-08-28
DE60003188T2 (de) 2004-07-01
HUP9902559A3 (en) 2003-05-28
ES2197107T3 (es) 2004-01-01
HRP20020071A2 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
EP0993831A3 (en) Compounds and compositions for delivering active agents
EA200301275A1 (ru) Капсулы для ингаляции
IL140710A0 (en) Pulmonary delivery of active agents
ZA200410109B (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability.
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
WO2004026836A3 (en) 1-pyridin-4-yl-urea derivatives
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
AU2001228811A1 (en) Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
WO2002015959A3 (en) Compounds and compositions for delivering active agents
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO2002015933A3 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
SI1200088T1 (en) Paracetamol and drotaverine containing composition
MX9505192A (es) Utilizacion de un antagonista de la substancia p para la obtencion de composiciones farmaceuticas para el tratamiento del enrojecimiento cutaneo de origen neurogenico.
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
NO20012673D0 (no) Nytt farmasöytisk preparat og fremgangsmåte for dets fremstilling
AU2003269871A1 (en) Radiosensitizer composition containing n-acetylphytosphingosine analogs and n,n-dimethyl-phytosphingosine analogs as the active ingredients
SE0000303D0 (sv) Novel compounds
WO2001070184A3 (en) A composition containing monoterpenes for topical oral administration
BR0313076A (pt) Sal de ácido orgânico de amlodipina
MXPA04006269A (es) Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.
WO2002002763A3 (en) Recombinant staphylococcus aureus peptide deformylase
DE60210308D1 (de) Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure
TW200621304A (en) Pharmaceutical composition
MXPA04006675A (es) Composicion farmaceutica que comprende glitazona y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.